Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Debt / NOTE 6.000% 5/1
-
Unit price / market price
-
$0.7354
-
Total 13F principal
-
$102,115,871
-
Principal change
-
$0
-
Total reported value
-
$79,947,428
-
Number of holders
-
4
Institutional Holders of KARYOPHARM THERAPEUTICS INC - NOTE 6.000% 5/1 as of Q3 2025
As of 30 Sep 2025 KARYOPHARM THERAPEUTICS INC - NOTE 6.000% 5/1 had 4 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of $102,115,871 principal (par value or face value) of the bond of the company.
Largest 4 bondholders included BRAIDWELL LP, Davidson Kempner Capital Management LP, HIGHBRIDGE CAPITAL MANAGEMENT LLC, and Context Capital Management, LLC.
This table shows 4 bond principal holders of the security as of 30 Sep 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.